Compare GRFS & CSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | CSW |
|---|---|---|
| Founded | 1940 | 2014 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.2B |
| IPO Year | 2008 | 2014 |
| Metric | GRFS | CSW |
|---|---|---|
| Price | $8.21 | $277.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $10.37 | ★ $342.86 |
| AVG Volume (30 Days) | ★ 699.5K | 96.7K |
| Earning Date | 07-28-2022 | 10-29-2026 |
| Dividend Yield | ★ 3.24% | 0.43% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.94 |
| Revenue | N/A | N/A |
| Revenue This Year | $2.18 | $20.90 |
| Revenue Next Year | $6.15 | $5.12 |
| P/E Ratio | ★ $18.67 | $46.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.96 | $244.24 |
| 52 Week High | $9.77 | $355.48 |
| Indicator | GRFS | CSW |
|---|---|---|
| Relative Strength Index (RSI) | 48.74 | 44.67 |
| Support Level | $7.52 | $274.66 |
| Resistance Level | $8.29 | $302.61 |
| Average True Range (ATR) | 0.24 | 12.07 |
| MACD | -0.05 | -0.50 |
| Stochastic Oscillator | 0.54 | 28.58 |
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms & domain expertise across three segments: Contractor Solutions, Engineered Building Solutions, & Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient & performance-enhancing products for residential & commercial HVAC/R & plumbing applications, which are designed for professional end-use customers. The majority of the company's revenue is generated from the Contractor Solutions segment in the U.S. markets. products include mechanical products for heating, ventilation, air conditioning, & refrigeration, plumbing products, grilles, registers, & diffusers, building safety solutions, & high-performance specialty lubricants & sealants.